NEW YORK, June 20, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company announced today that Dr. Daniel Teper, Chief Executive Officer, will be presenting at the JMP Securities Life Sciences Conference on Tuesday, June 21, 2016 at 11:00 AM local time in the Astor room at the St Regis Hotel, New…